P04049 (RAF1_HUMAN) Homo sapiens (Human)
RAF proto-oncogene serine/threonine-protein kinase UniProtKBInterProSTRINGInteractive Modelling
648 aa; Sequence (Fasta) ; (Isoform 2);
9 identical sequences: Homo sapiens: L7RRS6; Pongo abelii: Q5R5M7, A0A2J8TVZ9; Theropithecus gelada: A0A8D2FDX4; Papio anubis: A0A096NYS4; Macaca nemestrina: A0A2K6DFP8; Macaca mulatta: F6SWC0; Cercocebus atys: A0A2K5MHK1; Nomascus leucogenys: G1QXT4
It is possible new templates exist for this target since these models were created.
Available Structures
54 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Cryo-EM structure of CRaf dimer with 14:3:3 |
Heteromer A0A9R0D7T1; | 99.63 | ||||
| cryo-EM Structure of Craf:14-3-3:Mek1 |
Heteromer A0A9R0D7T1; Q02750; | 99.64 | 2×29L; | |||
| CryoEM structure of activated CRAF/MEK/14-3-3 complex with NST-628 |
Heteromer P31947; Q02750; | 100.0 | 2×A1AHE; | |||
| Crystal structure of CRAF/MEK complex with NST-628 and active RAF dimer |
Heteromer Q02750; | 100.0 | 2×A1AHE; 2×ANP; 2×MG; | |||
| Activated CRAF/MEK heterotetramer from focused refinement of CRAF/MEK/14-3-3 complex |
Heteromer Q02750; | 100.0 | 2×A1AHE; | |||
| Crystal structure of CRAF/MEK1 complex with NST-628 and inactive RAF |
Heteromer Q02750; | 100.0 | 2×ANP; 2×MG; 1×NI; 5×ACT; 1×EDO; 1×A1AHE; | |||
| Structure of the RAF1-HSP90-CDC37 complex (RHC-II) |
Heteromer P08238; Q16543; | 98.96 | 2×ATP; | |||
| Structure of the RAF1-HSP90-CDC37 complex (RHC-I) |
Heteromer P08238; Q16543; | 98.96 | 2×ATP; 2×MG; | |||
| Hsp90 provides platform for CRaf dephosphorylation by PP5 |
Heteromer P08238; P53041; Q16543; | 100.0 | 1×ADP; 2×MG; 2×K; 1×ATP; 2×MN; | |||
| Hsp90 provides platform for CRaf dephosphorylation by PP5 |
Heteromer P08238; P53041; Q16543; | 100.0 | 2×K; 2×MG; 1×ADP; 1×ATP; 2×MN; | |||
| Cryo-EM structure of the RAF1-HSP90-CDC37 complex in the closed state |
Heteromer A0A7E5VSK5; Q16543; | 100.0 | 2×ATP; 2×MG; | |||
| Crystal Structure of KRAS-G13D (GMPPNP-bound) in complex with RAS-binding domain (RBD) and cysteine… |
Heteromer P01116; | 100 | 1×GNP; 1×MG; 3×ZN; 2×GOL; 1×CL; | |||
| Crystal Structure of wild-type KRAS (GMPPNP-bound) in complex with RAS-binding domain (RBD) and cys… |
Heteromer P01116; | 100 | 1×GNP; 1×MG; 3×CL; 2×GOL; 1×IPA; 2×ZN; | |||
| Crystal Structure of KRAS-Q61R (GMPPNP-bound) in complex with RAS-binding domain (RBD) and cysteine… |
Heteromer P01116; | 100 | 1×GNP; 1×MG; 3×ZN; 2×GOL; | |||
| Crystal Structure of KRAS-G12V (GMPPNP-bound) in complex with RAS-binding domain (RBD) and cysteine… |
Heteromer P01116; | 100 | 1×GNP; 4×GOL; 1×MG; 2×CL; 2×ZN; | |||
| Crystal structure of HRas in complex with the Ras-binding and cysteine-rich domains of CRaf-kinase |
Heteromer P01112; | 100.0 | 1×GNP; 1×MG; 2×ZN; | |||
| Crystal Structure of KRAS4a (GMPPNP) in complex with RAF1 (RBD-CRD) |
Heteromer P01116; | 100 | 1×GNP; 1×MG; 2×ZN; | |||
| NMR data-driven model of KRas-GMPPNP:RBD-CRD complex tethered to a nanodisc (state A) |
Heteromer P01116; P02647; | 99.24 | 64×PCW; 16×17F; 1×GNP; 1×MG; 2×ZN; | |||
| NMR data-driven model of KRas-GMPPNP:RBD-CRD complex tethered to a nanodisc (state B) |
Heteromer P01116; P02647; | 99.24 | 64×PCW; 16×17F; 1×GNP; 1×MG; 2×ZN; | |||
| Crystal Structure of wild-type KRAS (GMPPNP-bound) in complex with RAS-binding domain (RBD) and cys… |
Heteromer P01116; | 100.0 | 1×GNP; 1×MG; 2×SO4; 5×CL; 3×ZN; | |||
| Crystal Structure of wt H-Ras-GppNHp bound to the RBD of Raf Kinase |
Heteromer P01112; | 100 | 1×GNP; 2×CA; 1×MG; 1×ACT; 1×DTU; | |||
| Crystal Structure of wild-type KRAS4b (GMPPNP-bound) in complex with RAS-binding domain (RBD) of RA… |
Heteromer P01116; | 100 | 1×MG; 1×GNP; 3×CL; 2×EDO; 1×MPD; | |||
| CRYSTAL STRUCTURE OF RAP.GMPPNP IN COMPLEX WITH THE RAS-BINDING-DOMAIN OF C-RAF1 KINASE (RAFRBD). |
Heteromer P62834; | 100 | 1×MG; 1×GTP; 1×CA; | |||
| Crystal Structure of Q61L H-Ras-GppNHp bound to the RBD of Raf Kinase |
Heteromer P01112; | 100 | 1×GNP; 1×MG; | |||
| Crystal structure of KRAS4a (GMPPNP) in complex with RAF1 (RBD) |
Heteromer P01116; | 100.0 | 1×MG; 1×GNP; | |||
| Complex of Rap1A(E30D/K31E)GDP with RafRBD(A85K/N71R) |
Heteromer P62834; | 97.37 | 1×GDP; 1×MG; 1×CA; | |||
| HUMAN RAP1A, RESIDUES 1-167, DOUBLE MUTANT (E30D,K31E) COMPLEXED WITH GPPNHP AND THE RAS-BINDING-DO… |
Heteromer P62834; | 100 | 1×MG; 1×GNP; 1×CA; | |||
| Crystal Structure of KRAS4b-G13D (GMPPNP-bound) in complex with RAS-binding domain (RBD) of RAF1/CR… |
Heteromer P01116; | 100.0 | 1×GNP; 1×MG; | |||
| Complex of Ras-GDP with RafRBD(A85K) |
Heteromer P01112; | 98.68 | 1×GDP; 1×MG; | |||
| Crystal Structure of G12V HRas-GppNHp bound in complex with the engineered RBD variant 1 of CRAF Ki… |
Heteromer P01112; | 84.13 | 1×GNP; 1×GOL; 1×MG; | |||
| Crystal Structure of G12V HRas-GppNHp bound in complex with the engineered RBD variant 12 of CRAF K… |
Heteromer P01112; | 85.94 | 1×MG; 1×GNP; | |||
| 14-3-3 isoform zeta in complex with a diphoyphorylated C-RAF peptide |
Heteromer P63104; | 100.0 | ||||
| Human 14-3-3 isoform zeta in complex with a diphoyphorylated C-RAF peptide and Cotylenin A |
Heteromer P63104; | 100.0 | 2×K; 2×1F5; | |||
| Small molecule stabilizer (compound 7) for C-RAF and 14-3-3 |
Heteromer P31947; | 100 | 2×CL; 4×MG; 2×L6L; | |||
| Small molecule stabilizer (compound 8) for C-RAF and 14-3-3 |
Heteromer P31947; | 100 | 2×CL; 4×MG; 2×O56; | |||
| Small molecular stabilizer for C-RAF (pS259) and 14-3-3 (1075306) |
Heteromer P31947; | 100 | 2×CL; 6×MG; 2×O5I; | |||
| Small molecule stabilizer (compound 5) for C-RAF(pS259) and 14-3-3 |
Heteromer P31947; | 100 | 6×MG; 2×L7U; | |||
| Small molecular stabilizer for C-RAF (pS259) and 14-3-3 (1075297) |
Heteromer P31947; | 100 | 2×CL; 4×MG; 2×O6L; | |||
| Impaired binding of 14-3-3 to Raf1 is linked to Noonan and LEOPARD syndrome |
Heteromer P63104; | 100 | 1×PPI; | |||
| Impaired binding of 14-3-3 to Raf1 is linked to Noonan and LEOPARD syndrome |
Heteromer P63104; | 100 | 2×MG; 1×PPI; | |||
| Crystal Structure of human 14-3-3 sigma in Complex with Raf1 peptide (10mer) |
Heteromer P31947; | 100 | 2×CL; 6×MG; | |||
| small molecule stabilizer (compound 1) for C-RAF pS259 and 14-3-3 |
Heteromer P31947; | 100 | 2×CL; 6×MG; 2×O6C; | |||
| 14-3-3 isoform sigma in complex with a phosphorylated C-RAF peptide |
Heteromer P31947; | 100 | ||||
| Structure of 14-3-3 isoform sigma in complex with a C-Raf1 peptide and a stabilizing small molecule… |
Heteromer P31947; | 100 | 2×M1T; | |||
| Crystal Structure of human 14-3-3 sigma in Complex with Raf1 peptide (6mer) |
Heteromer P31947; | 100 | 2×CL; 6×MG; | |||
| Crystal Structure of human 14-3-3 sigma in Complex with Raf1 peptide (6mer) and stabilisator Fusico… |
Heteromer P31947; | 100 | 2×FSC; 4×CL; 8×MG; | |||
| Crystal structure of c-raf (raf-1) | homo-2-mer | 100.0 | 2×SM5; | |||
| CRAF ras-binding domain chimera, ligand complex | monomer | 97.67 | 1×USX; | |||
| CRAF ras-binding domain chimera, apo form | monomer | 97.67 | ||||
| solution-structure of Ras Binding Domain (RBD) in C-RAF | monomer | 100 | ||||
| solution structure of Ras Binding Domein (RBD) in C-RAF with negative allosteric modulator. | monomer | 100 | ||||
| NMR SOLUTION STRUCTURE OF THE RAS-BINDING DOMAIN OF C-RAF-1 | monomer | 100 | ||||
| RAF-1 CYSTEINE RICH DOMAIN, NMR, MINIMIZED AVERAGE STRUCTURE | monomer | 100 | 2×ZN; | |||
| RAF-1 CYSTEINE RICH DOMAIN, NMR, 27 STRUCTURES | monomer | 100 | 2×ZN; | |||
3 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8dgt.1.A | monomer | 0.62 | 2×ZN; | 63.60 | ||
| 8dgs.1.A | monomer | 0.58 | 1×AGS; 2×ZN; | 63.60 | ||
| 7z38.1.C | monomer | 0.54 | 99.69 | |||
3 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 8dgt.1.A | monomer | 0.60 | 2×ZN; | 64.05 | ||
| Isoform 2 | 8dgs.1.A | monomer | 0.58 | 1×AGS; 2×ZN; | 64.05 | ||
| Isoform 2 | 7z38.1.C | monomer | 0.55 | 99.69 | |||